Voximetry Gets FDA Clearance
Voximetry received 510(k) market clearance from the U.S. Food and Drug Administration for its Torch Dose Assessment for Radiopharmaceutical Therapy, the company announced recently. According to a release, Torch can…
Category Archives: Biotech
Plumb Pharmaceuticals Gets Investment from Winnow Fund
Plumb Pharmaceuticals announced recently that it received an investment from the Winnow Fund earlier this year. The company did not reveal the investment amount. Plumb Pharmaceuticals is currently developing its…
Venture Investors, SWIB Invest in HistoSonics
Venture Investors and the State of Wisconsin Investment Board participated in a $100 million financing round for HistoSonics, which made the announcement today. The Minneapolis-based HistoSonics is a developer of…
Exact Sciences’ POLAR Predicts Therapy Benefit
Exact Sciences’ announced today its initial clinical validation data for its Profile for the Omission of Local Adjuvant Radiotherapy (POLAR). According to a release, POLAR is the first genomic signature…
NorthStar Breaks Ground on New Facility
NorthStar Medical Radioisotopes has broken ground on a new facility that will house a planned contract development and manufacturing business unit called Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), the…
Cellular Logistics Earns $337K SBIR Grant
Cellular Logistics announced recently that it is the recipient of a second Phase I SBIR Grant through the National Institutes of Health, this one worth $337,000. According to a release,…
BioForward Reports on Industry’s Economic Impact
Wisconsin’s biohealth industry generated nearly $32 billion in total economic impact in 2021 and supports nearly 129,000 jobs, according to a report funded by BioForward. “The report highlights the immense…
Venture Investors Invests in Delphinus
Venture Investors was part of a $30 million Series D financing round for Delphinus, the company announced today. The Detroit-based Delphinus, a medical imaging company, developed SoftVue, the first circular…
Cellectar Awarded $2M Grant
Cellectar Biosciences has been awarded $1.98 million in additional grant funding by the National Institute of Health’s National Cancer Institute (NCI), the company announced today. According to a release, the…
SHINE, Radiopharm Theranostics Establish Agreement
SHINE Technologies and Radiopharm Theranostics signed a clinical supply agreement, in which SHINE will supply Radiopharm with isotope non-carrier-added lutetium-177 (Lu-177), the company announced recently. “One way or another, nearly…
